Related Experiment Video
Updated: May 22, 2026

The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
Decreased plasma nesfatin-1 levels in patients with generalized anxiety disorder
Huseyin Gunay1, Recep Tutuncu, Suleyman Aydin
1Department of Psychiatry, Etimesgut Military Hospital, Ankara, Turkey.
Abstract:
Nesfatin-1, a recently discovered satiety molecule, is localized in neurons of the hypothalamus and brain stem and colocalized with stress-related substances. However, the relation between nesfatin-1 and stressor related behaviors like anxiety and/or fear has not yet been investigated in human subjects. In the present study, our aim was to investigate whether there was a relationship between plasma nesfatin-1 levels and generalized anxiety disorder. The study group consisted of 40 patients (BMI, 22.98 ± 0.56) with generalized anxiety disorder and 34 age-matched healthy male control subjects (23.05 ± 0.4). Patients fully met the fourth Diagnostic and Statistical Manual of Mental Disorders, text revision. Blood samples for nesfatin-1 were drawn at the end of an overnight fasting period at least 10h. Plasma nesfatin-1 levels were measured and found significantly lower in anxiety disorder group than in control group (0.35 ± 0.037 ng/ml vs. 0.63 ± 0.080 ng/ml, respectively, p<0.05). Low nesfatin-1 levels may be related with generalized anxiety disorder.
Related Concept Videos
Generalized Anxiety Disorder
Nephrotic Syndrome I : Introduction
Social Anxiety Disorder
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Nephrotic Syndrome III : Nursing Management
Hypoglycemia and Glucagon

